Topic 3 Genetic Disorders
Topic 3 Genetic Disorders
• Genetics
-Study of why disorders occur
Nature of Inheritance
• Genes
– Basic units of heredity; structures
responsible for hereditary characteristics
– May or may not be expressed or passed to the
next generation
– According to Mendel’s Law, one gene for each
hereditary property is received from each parent;
one is dominant (expressed); one is recessive
Karyotype
• Chromosomal pattern of a cell including genotype,
number of chromosomes and normality or
abnormality of the chromosomes
Genotype
• Actual gene composition; Sequence and
combination of genes on a chromosome
Phenotype
• Outward appearance or observable expression
of genes (hair color, eye color, body build, allergies)
Alleles
• Pairs of genes located on the same site on
paired chromosomes
• Homozygous alleles (DD or dd)
• Heterozygous alleles are two different
alleles for the same trait (Dd)
CONGENITAL and GENETIC are not synonymous
Diagnostic testing
• Karyotyping – visual presentation of
chromosomes (sample: peripheral venous
blood; scraping of cells from buccal membrane)
• Barr body determination – if a child is born with
ambiguous genitalia; scraping of cells from
buccal membrane; stained and magnified;
presence of nondominant X chromosome in
the nucleus- Barr body (chromosomally female)
Assessing for Genetic Disorders
AFP analysis
• alpha fetoprotein (AFP) is a glycoprotein produced by
the fetal liver
• AFP level in the amniotic fluid or maternal serum will
differentiate from normal if a chromosomal or a spinal
cord disorder is present (eg, in mothers who have
gestational diabetes; infants 10x risk of having a neural
tube defect)
• Serum test is done at 15th week of pregnancy; if result
is abnormal, amniotic fluid will be assessed
• elevated 3-5x in amniotic fluid secondary to leakage
from open neural tube
• low AFP, < 5% Down syndrome
• maternal serum AFP has a false positive rate 30%; use
of triple study (AFP, estriol and hCG) reduces false
positive rate
Assessing for Genetic Disorders
Chorionic villi sampling
• Retrieval and analysis of chorionic villi for chromosome analysis
• Transcervical or transabdominal; may be done as early as 5
weeks, but more commonly done at 8-10 weeks of pregnancy
• Risks: bleeding/ loss of pregnancy; limb reduction syndrome;
infection
• Diagnosis of Sickle cell disease, thalassemia
Chronic villi sampling
Assessing for Genetic Disorders
Amniocentesis
• Withdrawal of amniotic fluid from the
abdominal wall for analysis at 14th to 16th
week of pregnancy
• May include karyotyping, analysis of AFP and
acetylcholinesterase
• Used to diagnose potential genetic problems
in the fetus (Down Syndrome), to estimate
fetal lung maturity or to diagnose fetal
hemolytic disease
Amniocentesis
Assessing for Genetic Disorders
Percutaneous umbilical blood sampling
• removal of blood from the umbilical cord using an amniocentesis
technique
• more rapid karyotyping
Preimplantation diagnosis
• may be possible in the future
• to remove the fertilized ovum from the uterus
before implantation for biopsy or cell analysis
Legal and Ethical Aspects
• 3 Number 18 chromosomes
• Severely cognitively challenged
• Incidence .23 per 1,000 live births
• Small for gestational age (SGA)
• Low set ears, small jaw, congenital heart defects, misshapen
fingers and toes (Index deviates or crosses over other fingers)
• Soles of the feet are rounded not flat (rocker-bottom feet)
• Do not survive beyond early infancy
3. Cri-du-chat syndrome